<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "rasburicase inj VIAL>
<dose><value>0.1 - 0.2</value>
<value>0.15 - 0.2</value>
<value>0.2</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drug><value>rasburicase inj VIAL</value>
</drug><strength><value>1.5 mg</value>
</strength><frequency><value>DAILY</value>
<value>BID</value>
</frequency><instruction><value></value>
<value>for 3 days.</value>
</instruction><volume><value></value>
</volume><units><value>mg/kg</value>
<value>mg/kg/day</value>
</units><additionalnotes><value>Treatment up to 7 days.</value>
<value></value>
</additionalnotes><population><value>ADULT. Hyperuricemia.</value>
<value>CHILDREN, over 1 month of age. Tumor Lysis Syndrome</value>
<value>ADULT. Hyperuricemia in cancer patients.</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=1983</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Enzymes</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>